IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference Transcript
All right. Good afternoon, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, the biotech analyst here. And it's my pleasure to introduce Fred Schwarzer, CEO of IGM Biosciences. Format for today is a fireside chat. But just before we get started, I need to read a quick disclaimer. For important disclosures, please see the Morgan Stanley research website at www.morganstanley.com\researchdisclosures.
(Operator Instructions)
Questions & Answers
And with that, we can just hop straight into Q&A and maybe Thanks, Fred, for joining us here. And maybe if there's people who aren't familiar with IGM Biosciences, -- maybe you can just talk about some of the key differences between an IGM antibody and an IGG antibody and maybe why people have seemed to focus on IGG?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |